Search Within

Subhiksha Nandakumar

  1. "Radiology, Department of"
Formats
  1. Meeting Abstract (7)
  2. Journal Article (6)
  3. Correspondence (1)
  4. Research Letter (1)
Groups
  1. Radiology, Department of (15)
  2. GSK Faculty (12)
  3. Human Oncology and Pathogenesis Program (11)
  4. Department of Pathology and Laboratory Medicine (10)
  5. Epidemiology and Biostatistics (10)
  6. Department of Medicine (9)

More Groups

People
  1. Ingo Mellinghoff (9)
  2. Anne Reiner (8)
  3. Robert Young (8)
  4. Nikolaus Schultz (7)
  5. Michael Berger (5)
  6. Nagavarakishore Pillarsetty (5)

More People

Years
  1. 2025 (1)
  2. 2024 (8)
  3. 2023 (2)
  4. 2022 (1)
  5. 2021 (2)
  6. 2019 (1)
Publications
  1. Clinical Cancer Research (5)
  2. Neuro-Oncology (4)
  3. Journal of Clinical Oncology (2)
  4. Acta Neuropathologica (1)
  5. Cancer Research (1)
  6. Cell Reports (1)

More Publications

Publishers
  1. American Association for Cancer Research (6)
  2. Oxford University Press (4)
  3. American Society of Clinical Oncology (2)
  4. Cell Press (1)
  5. Society of Nuclear Medicine (1)
  6. Springer (1)

Results (15)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • BCL2 drives castration resistance in castration-sensitive prostate cancer by orchestrating reciprocal crosstalk between oncogenic pathways
    Journal Article

    Hirani, R.; Nandakumar, S.; Zaman, N.; Prabhakaraalva, P.; King, S. A.; Kalidindi, T. M.; Ghale, R.; Rajanala, S. H.; Fidele, D. C.; De Stanchina, E.; more...
    Cell Reports (2025)

    Fulltext@MSK | Save
  • Prospective germline sequencing of patients with gliomas, glioneuronal or neuronal tumors
    Meeting Abstract

    Lin, A.; Nandakumar, S.; Mehine, M.; Kemel, Y.; Mandelker, D.; Karajannis, M.; Sait, S. F.; Gavrilovic, I.; Pentsova, E.; Schaff, L.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Utility of circulating tumor DNA (ctDNA) from cerebrospinal fluid (CSF) for prognosis of patients with recurrent high-grade glioma
    Meeting Abstract

    Miller, A. M.; Nandakumar, S.; Holle, B. M.; Kreitzer, C.; Song, T.; Tartaro, M.; Hertz, C. A. J.; Rafailov, J.; Campos, C.; Brannon, A. R.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Utility of circulating tumor DNA (CTDNA) from cerebrospinal fluid (CSF) for prognosis of patients with recurrent high-grade glioma
    Meeting Abstract

    Holle, B. M.; Nandakumar, S.; Kreitzer, C.; Song, T.; Tartaro, M.; Hertz, C. A. J.; Rafailov, J.; Campos, C.; Reiner, A. S.; Young, R.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • A phase II study assessing long-term response to ibrutinib monotherapy in recurrent or refractory CNS lymphoma
    Journal Article

    Grommes, C.; Nandakumar, S.; Schaff, L. R.; Gavrilovic, I.; Kaley, T. J.; Nolan, C. P.; Stone, J.; Thomas, A. A.; Tang, S. S.; Wolfe, J.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Utility of circulating tumor DNA (ctDNA) from cerebrospinal fluid (CSF) for prognosis of patients with recurrent high grade glioma
    Meeting Abstract

    Holle, B. M.; Nandakumar, S.; Kreitzer, C.; Song, T.; Tartaro, M.; Hertz, C. A.; Rafailov, J.; Campos, C.; Reiner, A. S.; Young, R. J.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • CEACAM5-targeted immuno-PET in androgen receptor-negative prostate cancer
    Journal Article

    Imberti, C.; De Gregorio, R.; Korsen, J. A.; Hoang, T. T.; Khitrov, S.; Kalidindi, T.; Nandakumar, S.; Park, J.; Zaidi, S.; Pillarsetty, N. V. K.; more...
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • Tumor volume growth as surrogate endpoint in IDH-mt glioma — Response
    Correspondence

    Bhatia, A.; Moreno, R.; Reiner, A. S.; Nandakumar, S.; Walch, H. S.; Malani, R.; Panageas, K. S.; Mellinghoff, I. K.; Bale, T. A.; Young, R. J.
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Tumor volume growth rates and doubling times during active surveillance of IDH-mutant low-grade glioma
    Journal Article

    Bhatia, A.; Moreno, R.; Reiner, A. S.; Nandakumar, S.; Walch, H. S.; Thomas, T. M.; Nicklin, P. J.; Choi, Y.; Skakodub, A.; Malani, R.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Tumor volume growth rates and doubling times during active surveillance of IDH-mutant low-grade glioma
    Meeting Abstract

    Bhatia, A.; Moreno, R.; Reiner, A.; Nandakumar, S.; Walch, H.; Thomas, T.; Nicklin, P.; Choi, C.; Skakodub, A.; Malani, R.; more...
    Neuro-Oncology (2023)

    Fulltext@MSK | Save